Many Americans Don't Get Recommended Vaccines Before Travel
Americans who travel abroad often do not receive the recommended vaccines that would protect them from certain illnesses, new research suggests. One study of Americans visiting travel clinics found that more than half of those who were recommended to get a measles vaccination did not do so before traveling. Another study found that more than two dozen Americans were sickened with hepatitis A while visiting a resort town in Mexico in early 2015. Although the hepatitis A vaccine is recommended for people going to Mexico, none of the people who got sick in this recent outbreak were vaccinated before traveling. "Americans planning international travel should see their health care providers or visit a travel clinic four to six weeks before the trip to learn what vaccines are recommended before heading to their destinations," said Dr. Emily Hyle, an instructor at Harvard Medical School in Boston, who led the measles vaccine study. About half of all U.S. measles case are tied to people who catch the disease while traveling abroad, Hyle said. "If we are more proactive about being sure that departing U.S. travelers have measles immunity, [this] could go a long way towards" reducing measles cases, Hyle said in a news conference today (Oct. 9). Both studies were presented here at IDWeek 2015, a meeting of several organizations focused on infectious diseases. For their study on measles vaccinations, Hyle and colleagues analyzed information from more tha...
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Currently in fellowship doing bread/butter procedures (MBB, epidurals, PNB, few SCS/PNS trials, etc.) and just interviewed at a private practice spot where they do a lot of procedures that I will have not done any training in prior to graduating (e.g. IT pump, SI fusion, Vertiflex, Kypho, MILD, Discectomy, lots of SCS/PNS trials etc) and significant amount of "OR pain procedures" at a very busy practice seeing 30-40 pts/day - how many of you are commonly performing these procedures and are... private practice concern
Publication date: October 2020Source: Brain, Behavior, and Immunity, Volume 89Author(s): Fernando Lopes, Fernando A. Vicentini, Nina L. Cluny, Alexander J. Mathews, Benjamin H. Lee, Wagdi A. Almishri, Lateece Griffin, William Gonçalves, Vanessa Pinho, Derek M. McKay, Simon A. Hirota, Mark G. Swain, Quentin J. Pittman, Keith A. Sharkey
BEST supplements to relieve joint pain: Is your arthritis playing up? The wetter and colder months could partially be to blame. These two pills may help.
Authors: Kim H, Lim YM, Lee EJ, Kim HW, Ahn HS, Kim KK PMID: 33029979 [PubMed]
CONCLUSIONS: More than half of the iIONP patients had an enhanced oculomotor nerve in MRI. A few of them also had elevated CSF IgG synthesis rate, but no further evidence for inflammation was found. The administration of steroids seemed to have no benefit other than increasing the blood glucose level. PMID: 33029972 [PubMed]
Publication date: Available online 10 October 2020Source: Journal of Clinical and Experimental HepatologyAuthor(s): Pramod Kumar, Anand Kulkarni, Mithun Sharma, Padaki Nagaraja Rao
Publication date: Available online 10 October 2020Source: Journal of Acupuncture and Meridian StudiesAuthor(s): Natália Freire Valente, Eliezer de Sousa Cardoso, Juliana Alencar da Silva Resende, Jeferson Antônio Santos
CONCLUSION: When gastroenterologists encounter NAFLD/NASH patients, serum CK should be verified. If hyperCKemia, frontal baldness, a hatched face, history of cataract surgery, and grip myotonia are noted, the possibility of MD may be considered. PMID: 33033573 [PubMed]
Authors: Tamai H, Shingaki N, Ida Y, Shimizu R, Maeshima S, Okamura J, Kawashima A, Nakao T, Hara T, Matsutani H, Nishikawa I, Higashi K Abstract BACKGROUND: Although clinical use of sofosbuvir plus ribavirin has been approved for patients infected with genotype 2 hepatitis C virus, patients ≥ 75-years-old have not been included in previous clinical trials. AIM: To evaluate the real-world safety and efficacy of sofosbuvir plus ribavirin for elderly patients (≥ 75-years-old) compared to nonelderly patients, we conducted a post-marketing prospective cohort study. METHODS: We treated 265 patients with ge...
More News: Back Pain | Centers for Disease Control and Prevention (CDC) | Children | Conferences | Epidemics | Epidemiology | Harvard | Health | Health Management | Hepatitis | Hepatitis A | Hepatitis Vaccine | Infectious Diseases | Jaundice | Learning | Measles | Measles Vaccine | Outbreaks | Pain | Science | Study | Tropical Medicine | Universities & Medical Training | Vaccines | Websites